 |
salmeterol xinafoate/fluticasone propionate |
|---|---|
| Trade Name | |
| Orphan Indication | Symptomatic exophthalmos associated with thyroid related eye disease |
| USA Market Approval | USA |
| USA Designation Date | 2009-10-29 00:00:00 |
| Sponsor | Lithera, Inc.;9191 Towne Center Drive;San Diego, California, 92122 |
